| OR | (95%CI) | p-value |
---|---|---|---|
Age at cancer diagnosis | |||
 ≤ 39 | 1 (ref) |  |  |
40–49 | 0.97 | (0.49–1.90) | 0.925 |
50–59 | 0.86 | (0.44–1.68) | 0.652 |
 ≥ 60 | 0.39 | (0.17–0.90) | 0.028* |
Time from cancer diagnosis, years | |||
0–4 | 1 (ref) |  |  |
5–9 | 0.91 | (0.57–1.45) | 0.692 |
 ≥ 10 | 0.55 | (0.32–0.96) | 0.037* |
Sex | |||
Male | 1(ref) | Â | Â |
Female | 0.64 | (0.34–1.22) | 0.177 |
Cancer stage | |||
Early (0, I) | 1(ref) | Â | Â |
Advanced (II, III, IV) | 1.81 | (1.13–2.90) | 0.014* |
Cancer site | |||
Intestinal | 1(ref) | Â | Â |
Gastric | 2.25 | (1.04–4.86) | 0.039* |
Breast | 1.05 | (0.39–2.81) | 0.923 |
Female genital | 2.09 | (0.81–5.41) | 0.129 |
Male genital | 0.29 | (0.06–1.36) | 0.116 |
Lung | 1.76 | (0.62–4.99) | 0.287 |
Urinary | 2.01 | (0.87–4.62) | 0.102 |
Hematological | 0.96 | (0.31–3.03) | 0.946 |
Head and neck | 1.56 | (0.63–3.86) | 0.334 |
Other | 2.10 | (0.89–4.98) | 0.091 |
Surgery | |||
No | 1(ref) | Â | Â |
Yes | 1.28 | (0.71–2.29) | 0.415 |
Chemotherapy | |||
No | 1(ref) | Â | Â |
Yes | 1.34 | (0.82–2.18) | 0.244 |
Radiotherapy | |||
No | 1(ref) | Â | Â |
Yes | 1.24 | (0.71–2.18) | 0.454 |